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Immunization against Group A streptococcal infections has been hampered by toxic 
properties of preparations of M protein employed as vaccines (1, 2). Intradermal injec- 
tions of purified preparations of M  protein in man have produced local inflammatory 
responses resembling cell-mediated reactions (1,  3-6).  Because  the reactions to  both 
rare and common M  serotypes occur with similar frequency and intensity (1), it has 
been suggested that the toxicity is due to impurities shared by many M  protein prep- 
arations. Theoretically, therefore, hypersensitivity to the type-specific  M antigen when 
isolated in pure form should be encountered only in the host specifically  immune to the 
homologous type. This concept is also supported by the resistance to phagocytosis of 
the intact M-rich streptococcus in fresh, nonimmune human blood in vitro (7). In such 
preparations the surface of the organism appears nonreactive with platelets and white 
blood cells (8). 
In our previous studies of delayed allergy to purified M protein in guinea pigs (2), we 
found  it  difficult to  produce  cell-mediated hypersensitivity that  was  entirely type 
specific. Such hypersensitivity could be demonstrated in young animals early in the 
course of the immune response but later, cross-reactivity to M  protein of other sero- 
types was usually encountered. These  cross-reactions were  considered to be due  to 
shared determinants among various serotypes of M  protein (9-11)  or, perhaps, to a 
trace contaminant of a potent toxic substance such as ceU-wall mucopeptide (12,  13). 
Subsequently,  we  have  attempted  to  separate  the  M  determinant  from 
antigens responsible for the inflammatory reactions by absorption experiments 
with  type-specific M  antiserum  (8).  In the  course  of  these  studies it became 
apparent  that  highly  purified  M  protein  preparations  have  potent  in  vitro 
cytotoxic effects  upon  platelets  and  polymorphonuclear  leukocytes  (PMN)? 
* These studies were supported in part by U. S. Public Health Service grant HE-09561 and 
by institutional Research  and Education funds from the Veterans Administration, Washing- 
ton, D. C. 
:~ Recipient of Research and Education (1968-1970) and Clinical Investigator (1970-1973) 
Awards from the Veterans Administration. 
1  Abbreviations used in this paper: PMN, polymorphonuclear  leukocytes; PRP, plate-rich 
plasma; THB, Todd-Hewitt broth. 
THE  JOURNAL OF  EXPERIMENTAL MEDICINE  • VOLUSi[E 134,  1971  351 352  CYTOTOXICITY  OF  STREPTOCOCCAL  M  PROTEIN 
Moreover,  homologous  type  antiserum  specifically  absorbed  these  cytotoxic 
properties.  This  report  describes  these  experiments  and  presents  evidence  to 
suggest that the toxic effects are due, at least in part,  to a  moiety of M  protein 
which carries the type-specific M  determinant. 
Materials  and Methods 
Streplococci.--The  strains of Group A streptococci used in this study included M  Types 6 
($43), 12 (SF42), and 30 (D24) which were obtained from Dr. Rebecca Lancefield, The Rocke- 
feller University, New York. In addition, an M  24 strain isolated from a patient with acute 
rheumatic fever and an M  56 strain from a patient with acute glomerulonephritis (14),  were 
used. Stock cultures of each serotype were stored, lyophilized, or frozen  (--65°C) in defibri- 
nated sheep blood or in Todd-Hewitt broth (THB)  supplemented with 20% normal rabbit 
serum. 
Extraction  and  Purification  ~[ M  Prolein.--Streptococci  rich in M  protein were grown in 
30-50 liter batches in THB, collected by continuous-flow centrifugation, washed in phosphate- 
buffered 0.9%  NaC1,  extracted  with hot  HCI,  and  purified  by  ribonuclease digestion and 
column chromatography as previously described  (2).  In addition to the methods previously 
described, purified M  protein fractions were obtained by gradient elution from columns of 
carboxymethyl-cellulose according to the method of Fox and Wittner (15). 
Titration  o[ the Type-Speclfic  M  Antigen.--Serial  twofold dilutions of M  protein solutions 
were made in 0.02 M phosphate-buffered 0.9% NaC1 at pH 7.4. Precipitin tests of each dilution 
were  made with standard  type-specific antisera obtained from The Communicable Disease 
Center,  Atlanta, Ga.,  by  the capillary tube method  of  Swift,  Wilson, Lancefield  (16).  The 
reciprocal of the highest dilution of a 1 mg/ml solution of M protein producing a type-specific 
precipitate was designated the "M titer." The immunochemical purity of M fractions was also 
checked, as previously described (2), by double-diffusion tests in agar gel with homologous-type 
unabsorbed antisera. Antisera were produced in rabbits by immunization with whole, heat- 
killed Group A streptococci according to the method of Lancefield (17). 
Human Blood.--Fresh  blood samples were obtained by venipuncture from healthy volun- 
teers and from the umbilical cord of infants during uncomplicated delivery of healthy mothers. 
The blood samples were immediately mixed with 10 units/ml of heparin to prevent clotting. 
All samples were used in tests within 2 hr after collecting. Cell-rich plasma rather than whole 
blood was used in some experiments and was obtained by allowing the erythrocytes in fresh, 
heparinized blood samples to sediment for  1 hr at room  temperature  (24°C)  in the plastic 
collecting syringe, held in vertical position, needle-end at the top. The collecting needle was 
replaced with a needle bent U-shaped. While maintaining the syringe in the vertical position, 
the supernatant cell-rich plasma was carefully ejected  through the bent needle into sterile 
plastic tubes, 
B~,~cterieidal- and  Phagocytosis-Inhibition  Tests.--In  vitro, indirect bactericidal and timed 
phagocytosis tests for type-specific M  antibody were performed as previously described  (18, 
19). In brief, bactericidal test mixtures consisted of 0.4 ml of fresh, heparinized human blood, 
0.05 ml of a standardized suspension of phagocytosis-resistant streptococci, and 0.05 ml rabbit 
antiserum against the homologous M  type. The mixtures were incubated at 37°C  in sterile 
rubber-stoppered test tubes by tumbling end-over-end in a rotator apparatus at 8 rpm for 3 hr. 
The number of surviving colonies was estimated by preparing pour-plates in 5% sheep blood 
agar. Phagocytosis test mixtures were similar to those used in bactericidal tests, except that a 
greater number of streptococci were added (approximately 10 streptococcal units/leukocyte). 
The percentage of polymorphonuelear leukocytes containing ingested streptococci (per cent of 
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prepared from a drop of the mixtures at 15, 30, and 60 min of incubation at 37°C in the rotator 
apparatus. 
The inhibitory effect of M protein preparations on each of the above tests was studied by 
incubating anti-M antiserum with various concentrations of homologous or heterologous sero- 
types of purified M  protein fractions for 30 min at 37°C.  Any precipitates which may have 
formed were removed by centrifugation at 1200 g for 20 min. The supernatant antiserum was 
then added to the test mixture containing homologous-type streptococci as described above. 
Platelet-Leukocyte Aggregation Tests.--The clumping and lyric effects of purified M protein 
on platelets and  polymorphonuclear leukocytes were studied  by examining stained  smears 
prepared from fresh blood-M protein mixtures by bright-field light microscopy or by examin- 
ing, by phase-contrast microscopy, a drop of cell-rich plasma incubated with M protein. 
Platelet aggregation was also studied by the turbidimetric method of Born (20). Platelet- 
rich plasma (PRP) was obtained by centrifuging fresh heparinized (10 units/ml) human blood 
at 226 g for 10 min at room temperature.  1 ml samples were transferred with a plastic pipette 
into siliconized 10 X  75 mm glass cuvettes. The PRP samples were stirred magnetically by 
adding a small teflon-coated iron bar to each tube. At 0.5-1 min intervals, the optical density 
was measured in a Coleman Jr. spectrophotometer adjusted to zero OD with distilled water at 
600 m/z. Each substance to be tested was added in a volume of 0.05 ml while the PRP was 
being stirred. The optical density of platelet-poor plasma, obtained by centrifuging PRP at 
1000 g for 15 min, was subtracted from each reading before plotting the results. 
PMN-Migration Tests.--The migration of human  blood  PMN in the absence and in the 
presence of various concentrations of M  protein was studied by the capillary tube method 
according to Bryant et al. (21). Test mixtures were prepared from 0.45 ml of heparinized blood 
and 0.05 ml of M protein dissolved in 0.02 M  phosphate-buffered 0.9% NaCI at pH 7.4. Imme- 
diately after mixing, sterile glass capillary tubes  (internal diameter, 0.8 mm)  were filled  to 
approximately 70% capacity. The tubes were then sealed with sterile modeling clay which had 
been coated with a thin layer of sterile silicone jelly. The sealed capillary tubes were centrifuged 
at 500 g for 10 min, mounted upright on lantern slide frames (Polaroid), and incubated vertically 
for 2 hr at 37°C.  At the end of incubation, the migration of PMN above the origin was esti- 
mated with an ocular micrometer on an American Optical dissecting microscope. 
RESULTS 
Cytotoxic effects of M  protein preparations  were first encountered  when the 
bactericidal test for type-specific anti-M antibody was employed to assay small 
amounts of M  protein (see Materials and Methods). This method was employed 
to identify the type-specific M  determinant  in our preparations  by its capacity 
to inhibit opsonization of homologous-type streptococci by M  antibody. In the 
course of these experiments,  it was noted  that  the addition  of an excess of M 
protein  to  the  system  inhibited  phagocytosis  non-type  specifically.  Stained 
smears  of  the  test  mixtures  showed  extensive  platelet-PMN  clumping  and 
destruction.  Systematic studies  of the effects of M  protein on blood samples in 
the absence of antiserum were, therefore, undertaken. 
Morphologic Effects of M Protein on Platelets and Leukocytes of Normal Human 
Blood.--The  addition  of  purified  type  24 M  protein  to  fresh  normal  human 
bloods in concentrations  of 0.1 I~g/ml  or greater  regularly  caused  clumping of 
platelets  and  leukocytes.  Higher  concentrations  fused  and  lysed  aggregated 
platelets and  caused vacuolization and  "smudging"  of PMN  (Fig.  1 a).  These 354  CYTOTOXICITY  OF  STREPTOCOCCAL  M  PROTEIN 
Fro. 1.  Blood smear stained with Wright's-Giemsa prepared after incubating fresh human 
blood for 15 min at 37°C with (a) M  24, 10/zg/ml, or (b) Type 24 streptococci, 2 ;<  10 s colony- 
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FIG. 2.  Platelet-PMN clumping effects of various concentrations  of purified  type 24  M 
protein mixed with cell-rich human plasma.  (a) Control, cell-rich plasma without M protein, 
(b) M 24, 0.1 #g/ml, (c) 1.0 #g/ml, (d) 10.0/zg/ml. Phase-contrast, X  700. 356  CYTOTOXICITY OF  STREPTOCOCCAL  M  PROTEIN 
morphologic changes in platelets and PMN were not observed in phagocytosis 
test mixtures when samples  of blood from the same  donors were mixed and 
incubated with live Type 24 Group A streptococci (108/ml) of the same strain 
from which the M  protein was extracted (Fig. 1 b). Live streptococcal strains 
of other M  serotypes, also rich in M  proteins and highly resistant to phago- 
cytosis, similarly were shown to produce no apparent effect when mixed with 
these bloods.  An unencapsulated,  M  protein-negative strain  (Type 1 av)  ~ of 
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FIG. 3.  Inhibition of PMN migration in fresh human blood mixed with various concentra- 
tions of purified M 24. 
Group A  streptococci which were highly susceptible to phagocytosis, on  the 
other hand, produced platelet-leukocyte clumps similar to those produced by 
purified M  protein. 
The clumping effects of various concentrations of purified M  protein mixed 
with fresh, cell-rich plasma samples were observed by phase-contrast micros- 
copy (Fig. 2). Platelet aggregation occurred within 5 min after mixing with M 
protein at concentrations between 0.1 and 100 #g/ml. In the range of approxi- 
mately 0.1-1.0 #g/ml, the platelets were loosely aggregated and most, whether 
aggregated  or  free,  were  unchanged  except for  occasional vacuolation  (Fig. 
2 b and 2 c). At these low concentrations, PMN  remained motile and morpho- 
2  Kindly supplied by Dr. Roger M. Cole, National Institute  of Allergy and Infectious 
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logically intact. The degree of platelet clumping paralleled M  concentration. 
Complete fusion  and  lysis were noted at  10/~g/ml  or greater  (Fig.  2 d).  At 
these higher concentrations PMN migrated toward the fused platelet clumps 
and a few PMN ingested deformed platelets at the periphery of the aggregates. 
The phagocytes then rapidly became vacuolated and lost motility. 
The Effect of M  Protein on the Migration of Blood PMN in Glass Capillary 
Tubes.--The sensitive method of the inhibition of leukocyte migration in glass 
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Fro. 4.  Comparison of the PMN migration-inhibitory capacities of three different M 6 
preparations. The M titers varied as follows:  Lot-PB, 256; Lot-EB, 128; and crude HC1 extract, 
32 (See also Table I). 
capillary tubes was  employed to  estimate  the  effect of M  protein on PMN 
motility  semiquantitatively.  The  results  of  a  typical  migration  experiment 
with serial dilutions of M 24 are depicted in Fig. 3. Purified M 24 at concentra- 
tions equal to, or greater than,  6.25/~g/ml completely inhibited PMN migra- 
tion.  At  the  higher  concentrations  (6.25/~g/ml  or  greater),  precipitation  of 
fibrinogen by M  protein was  observed, an  effect which  has been previously 
described (22, 23). 
The same morphological and functional changes at comparable concentra- 
tions of M  protein were observed in the bloods of six different normal adults 
and in umbilical cord blood from two normal infants. None of the above bloods 
contained  homologous  M  antibody by  opsonic  (bactericidal)  tests.  Purified 358  CYTOTOXICITY  OF  STREPTOCOCCAL  M  PROTEIN 
fractions of types 5,  6,  12,  30,  and 56 M  protein produced similar effects to 
those shown  for M  24.  The degree of toxicity varied with  the  M  titer  (see 
Materials  and Methods)  of each preparation. 
The Relation of "Purity" of M Protein to Inhibition of PMN M~gration.--The 
migration-inhibitory capacities of three different type 6 M  protein fractions of 
varying degrees of purity were compared. The M  titer of each fraction was 
determined by precipitin tests with the same lot of hyperimmune type-specific 
M 6 rabbit antiserum. The purity or specific activity of M protein preparations 
was defined in terms of the ratio of the reciprocal of the M  titer to the protein 
concentration of the sample, expressed as a function of ultraviolet light absorp- 
tion at 280 m/~. 
The degree of inhibition of PMN migration was directly proportional to the 
TABLE  I 
Comparison of PMN Migration Inhibition and Type-Specific Precipitating  Capacities of Crude 
and Purified M  6 
Reciprocal of highest dilution producing 
B  Ratio 
Preparation of M 6  A  50% inhibition of  A:B 
Type-specific precipitating  migration 
(M titer)  (toxicity) 
Crude acid extract  32  16  2:1 
Purified (Lot-EB)  128  64  2:1 
Purified (Lot-PB)  256  128  2:1 
purity of the M protein preparation (Fig. 4 and Table I). Thus, the ratio of the 
M  titer to the toxicity of each preparation of M  6 was constant (Table I). 
Type-Specific  Abosrptwn of the PMN Migration-Inhib*tory  Effect of Purified 
M  Protein.--To determine whether cytotoxicity was due to the type-specific M 
protein moiety itself, or to a  toxic moiety such as nmcopeptide which might 
have  been  co-purified along  with  the  M  determinant,  we  attempted  type- 
specific absorption with homologous antibody. Purified types 6, 24, and 56 M 
protein were incubated for 30 min  at 37°C  with  unabsorbed  homologous or 
heterologous,  hyperimmune  rabbit  antisera  to  Group  A  streptococci.  Pre- 
cipitates were removed by centrifugation and the supernatant solutions were 
tested in migration experiments. A typical migration experiment with antibody 
treated M  24 and M  6 is illustrated in Fig. 5. The capacity to inhibit PMN 
migration,  as well as  the capacity to precipitate plasma fibrinogen, were re- 
moved from the solution of each serotype of M  protein treated with homol- 
ogous, but not heterologous, antiserum (Table II). The neutralizing effect of 
antiserum  could be demonstrated  only after removing the type-specific pre- 
cipitates from the M  protein solutions. When left in suspension, the immune 
precipitates exhibited cytotoxic effects similar to those of untreated M protein. EDWIN  H.  BEACHEY  AND  GENE  H.  STOLLERMAN  359 
The  E~rect of Enzymatic  Digestion  with  Lysozyme  or  Trypsin  on  the  Cyto- 
toxicity of M Protein.--Because of the recently reported cytotoxicity of the muco- 
peptide  of streptococcal cell walls  (13),  the  question  arose whether  or not  a 
mucopeptide impurity might have been co-precipitated with the M  protein in 
FIG. 5. The effects of purified type 24 (M 24) and type 6 (M 6) M protein on migration of 
PMN in capillary tubes after absorption of M protein with type 6, 56, or 24 M antiserum or 
with normal rabbit serum (NRS). 
the above neutralization experiments. The cytotoxicity of streptococcal muco- 
peptide is abolished by digestion with lysozyme, but not trypsin (13).  M  pro- 
tein, on the other hand, is very sensitive to trypsin but not to lysozyme. Samples 
of type 24 M  protein were digested, therefore, with either lysozyme or trypsin 
and the digests were then tested for inhibition of leukocyte migration. Lysozyme 
digestion  showed  no  effect  whereas  trypsin  virtually  abolished  the  PMN 
migration-inhibitory effect of purified M protein (Table III). 
Turbidimetric  Studies  of  the  Platelet-Aggregating  Effects  of  M  Protein  and 360  CYTOTOXICITY OF  STREPTOCOCCAL M PROTEIN 
Cell-Wall  Mucopeptide.--Mucopeptide  3 isolated from Type 6  streptococci was 
sonicated with a  Branson  sonifier at 8  kc to achieve a  stable suspension. The 
mucopeptide  sonicate  was  then  compared  with  purified  M  6  in  platelet-ag- 
gregation  tests  by  the  turbidimetric  method.  M  protein  and  mucopeptide 
were tested at a final concentration of 50/zg/ml and compared with the aggre- 
gating effect of 2 ~M/ml of adenosine diphosphate (ADP). ADP has recently 
been  shown  to be intimately related  to  the phenomenon  of platelet aggrega- 
TABLE II 
Type-Specific Absorption  of Migration-Inhibiting  Capacity of Purified M  Protein with 
Streptococcal Antiserum 
% inhibition  of PMN migration  after absorption  with 
M protein 
Anti-24  Anti-6  Anti-56  NRS* 
(100 t*g/ml)  :~ 
Type 24  14  100  100  100 
Type 6  100  3  100  100 
Type 56  66  49  4  55 
* NRS, normal rabbit serum. 
:~ Concentration of M protein added to each absorbing serum. 
TABLE III 
The Effect of Trypsin or Lysozyme Digestion  on the Migration-Inhibitory  Capacity and 
Type-Specific Precipitin Reactivity of M  24 
M protein (1 mg/ml) treated with  M 24 precipitin  titer*  % inhibition  of PMN migration 
Not treated  256  100 
Trypsin (1%)  02  7 
Lysozyme  256  I00 
* See Materials and Methods. 
:~ Precipitin test with homologous  antiserum, negative at  1 mg/ml of M  protein after 
trypsin digestion. 
tion  (20,  24).  ADP  aggregated platelets immediately after  mixing.  M6  pro- 
duced  a  similar final degree of  aggregation after  an  initial delay of  approxi- 
mately  2  rnin.  In  contrast,  mucopeptide  produced  no  aggregation  after  10 
rain (Fig. 6). 
Preliminary  studies  suggest  that  the  cytotoxic  effects  of  M  protein  are 
mediated by serum factors.  Fresh blood cells were washed  twice in Tyrode's 
buffer and  resuspended  in  (a) Tyrode's buffer,  (b) fresh serum,  or (c) heated 
serum. Each suspension was treated with M  protein (100/~g/ml) for 30 rain at 
37°C.  The cells were again washed in Tyrode's buffer and finally resuspended 
Kindly supplied by Dr. Richard M. Krause, The Rockefeller University, New York. EDWIN  H.  BEACHEY  AND  GENE  H.  STOLLERMAN  361 
in fresh plasma. Control suspensions not treated with M protein were included 
in each experiment. 
PMN suspensions treated with M protein in Tyrode's buffer appeared  un- 
harmed and migrated normally when washed and resuspended in fresh plasma. 
PMN exposed to M protein in heated serum (56°C for 30 min)  appeared  nor- 
mal morphologically  before resuspension  in fresh  plasma.  After resuspension 
in fresh plasma,  however, they failed to migrate and stained smears revealed 
the characteristic  morphologic changes already described. 
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FIG. 6.  Aggregation produced in platelet-rich plasma by purified type 6 M protein, type 6 
cell-wall mucopeptide, and ADP. The final concentration of M protein and mucopeptide was 
50/~g/ml and that of ADP, 2 #M/ml. 
DISCUSSION 
The work reported here demonstrates the presence of a cytotoxic factor(s) 
which we were unable to separate from the type-specific M  determinant by 
the purification methods employed. The toxic factor(s)  could be removed from 
solutions  of  purified  M  protein  by  absorption  with homologous  type anti- 
serum, only. 
It is of interest that the M-anti-M complexes had to be removed by centri- 
fugation  before  the  cytotoxic  effects  could  be  prevented.  The  suspended 
M-anti-M precipitates remained toxic to platelets and PMN. The homologous 
M  antibody, therefore,  did not actually neutralize,  but rather absorbed  and 
removed, the toxic moiety along with the M determinant. 
Because  of this observation,  the possibility  was considered  that the toxic 
moiety could  have been  a  co-precipitated  contaminant with potent inflam- 
matory properties  such  as  mucopeptide,  even  though we have  consistently 362  CYTOTOXICITY OF  STREPTOCOCCAL  M  PROTEIN 
found  only minute  traces  of  the  carbohydrate  cell-wall  constituents  in  our 
purified preparations  (2).  Because  trypsin  digestion  abolished  the  cytotoxic 
activity of our M  preparations,  and treatment with lysozyme had no effect, 
the probability that mucopeptide was involved in the reactions to purified M 
proteins seems unlikely. Jones and Schwab  (13)  demonstrated that the cyto- 
toxic properties of streptococcal cell-wall mucopeptide was abolished by lyso- 
zyme but not by trypsin. 
Despite the close association of the toxic moiety with the M  determinant 
in purified M  protein preparations, the  intact  surface  of  the  M-rich  strep- 
toccus had no apparent effect on platelets and PMN in fresh blood samples. 
The extraction of M protein and the purification process may uncover common 
toxic determinants, perhaps buried in the M-associated, cell-wall fimbriae re- 
cently described by Swanson et al. (25). Antibodies to the uncovered antigens 
may be universally present in human blood but not previously demonstrated 
because of the emphasis upon type-specific immunity. 
The ready recognition by blood phagocytes of so-called "M-negative" Group 
A streptococci may actually be due to antibodies to such hypothetical, common 
antigenic determinants which remain exposed in the absence of a fully formed 
M  protein structure.  The clumping of platelets  and PMN produced by sus- 
pension in blood of the M-negative strain we employed suggests that the sur- 
face of such avirulent organisms contains substances with affinities similar to 
that of the toxic M moiety. In fact, previous studies  (26)  have demonstrated 
that  even  the  bloods  of  colostrum-deprived piglets and germfree mice react 
readily with M-negative Group A  streptococci to produce rapid phagocytosis 
and  that  thermostable  and  thermolabile  serum  factors  are  involved.  The 
surface of avirulent  strains  of Group A  streptococci, therefore, appear to be 
reactive with serum components that are present "naturally." The close associ- 
ation of such moieties with purified M  protein may account for its reactivity 
with  blood elements when removed from its  "protected" state  in  the intact 
surface structure of the virulent organism. 
The platelet-PMN reactions we have described present an additional mani- 
festation of cytotoxicity to that previously observed in studies of delayed al- 
lergy to purified M  protein in guinea pigs and man (2-6). Sensitized lympho- 
cytes do not appear to be involved in the platelet-PMN reactions observed in 
whole blood in  the present studies because  (a)  unbilical cord blood contains 
lymphocytes which, theoretically, are not yet sensitized to bacterial antigens 
and  (b) infants have shown relative tolerance to intradermal injections of M 
protein (5). Reactions to purified M  protein in cord blood were similar in in- 
tensity to those in adult blood. 
Some investigators (27, 28) have presented evidence that components closely 
associated with the type-specific M  determinant are involved in cross-reactions 
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of purified preparations to precipitate plasma fibrinogen (22, 23) and to opacify 
horse serum (29). 4 It appears, therefore, that the M determinant is associated 
with a  complex protein or family of proteins which possess  not only multiple 
antigenic determinants but varied biological activities. 
It is noteworthy that some of the toxic properties of M  protein are similar 
to those described for staphylococcal protein A  (30, 31).  Protein A  has the 
unique capacity to interact with immunoglobulin G  (IgG) by binding to the 
Fc portion of the molecule rather than to the antigen binding site (32). The com- 
plex of protein A and IgG can fix complement. Recently it has been reported 
that blood platelets are injured during the interaction of protein A  in blood 
samples (31).  The possibility that extracted M protein behaves similarly to pro- 
tein A should be explored. Avid phagocytosis of M-negative streptococci, like 
that of staphylococci, might relate to surface proteins with such avidities for 
immunoglobulins. 
SUlYIMARY 
Purified M  protein isolated from Group A streptococci produced cytotoxic 
reactions in normal human blood in vitro. In the presence of M antigen, plate- 
lets aggregated, fused, and lysed. Polymorphonuclear leukocytes (PMN)  sur- 
rounded  the platelet aggregates,  then became highly vacuolated and  lysed. 
In addition, PMN progressively lost their capacity to phagocytose unrelated 
bacteria and to migrate in glass capillary pipettes. 
Platelet-PMN  reactions  were  directly  proportional  to  the  type-specific 
precipitin reactivity of each M  preparation  and could be removed with ho- 
mologous M  antibody, only. Moreover, the reactivity of M  protein was abol- 
ished by enzymatic digestion with trypsin, but not with lysozyme, strongly 
suggesting that cell-wall mucopeptide was not involved. 
Preliminary studies showed that platelet-PMN reactions require heat-stable 
and  heat-labile  serum  factors,  presumably antibody and  complement.  It  is 
suggested that cytotoxic determinants are uncovered by  the extraction and 
purification process  and  are  intimately associated with the  type-specific M 
determinant, possibly in a molecular complex. 
We wish to acknowledge  the excellent technical  assistance of Mrs. Patricia Belew and Mrs. 
Connie Lawrence. 
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